File contents:
A. Cancer sites + stages
B. Modelled scenarios
C. Results codebook
D. Citation

*** A. Cancer sites + stages ***
11 cancer sites were included in the model

|Index|Site                  |ICD-O-3 Topography Code|
|-----|----------------------|-----------------------|
|0    |Oesophagus            |C15                    |
|1    |Stomach               |C16                    |
|2    |Colon                 |C18                    |
|3    |Rectum                |C19-20                 |
|4    |Anus                  |C21                    |
|5    |Liver                 |C22                    |
|6    |Pancreas              |C25                    |
|7    |Lung                  |C33-34                 |
|8    |Breast (females)      |C50                    |
|9    |Cervix uteri (females)|C53                    |
|10   |Prostate (males)      |C61                    |

4 cancer stages were modeled (TNM I-IV)

|Index|Stage|
|-----|-----|
|0    |I    |
|1    |II   |
|2    |III  |
|3    |IV   |

*** B. Modelled scenarios ***
Various scenarios were modelled: a baseline scenario of no scale-up, and different packages of scale-up in which we improved the availability of imaging and/or treatment modalities and 
quality of care to the mean level of high-income countries. 
Scenario names are used as prefixes for each results file.  

|Scenario              |Description                                                                                                                                                     |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Baseline              |[No scale-up]                                                                                                                                                   |
|Chemotherapy          |Scale-up of chemotherapy only                                                                                                                                   |
|Radiotherapy          |Scale-up of radiotherapy only                                                                                                                                   |
|Surgery               |Scale-up of surgery only                                                                                                                                        |
|Targeted_Therapy      |Scale-up of targeted therapy only                                                                                                                               |
|Treatment             |Scale-up of all treatment modalities (chemotherapy, radiotherapy, surgery, targeted therapy)                                                                    |
|Imaging               |Scale-up of all imaging modalities (ultrasound, x-ray, CT, MRI, PET, SPECT)                                                                                     |
|Trad_Treatment        |Scale-up of traditional treatment modalities (chemotherapy, radiotherapy, surgery)                                                                              |
|Trad_Treatment_Imaging|Scale-up of traditional treatment modalities (chemotherapy, radiotherapy, surgery) and imaging modalities (ultrasound, x-ray)                                   |
|Trad_All_Quality      |Scale-up of traditional treatment and imaging modalities and quality of care                                                                                    |
|Comprehensive         |Scale-up of all imaging and treatment modalities and quality of care                                                                                            |


*** C. Results codebook ***
Estimates for patients diagnosed in the Commonwealth in 2020

|File               |Contents                      |
|-------------------|------------------------------|
|[scenario]_Mean.csv|Estimated indicators - mean   |
|[scenario]_LB.csv  |Estimated indicators - 95% LB |
|[scenario]_UB.csv  |Estimated indicators - 95% UB |

Column headers

|Column Label      |Column Index|Description                                             |
|------------------|------------|--------------------------------------------------------|
|name              |           0|Name of country or Commonwealth grouping                |
|ISOCode           |           1|Country code  (ISO-3)                                   |
|deaths            |           2|Cancer deaths, all 11 cancers combined                  |
|surv_Overall      |           3|5-year net survival, all 11 cancers combined            |
|dx_Overall        |           4|Number of diagnosed cases, all 11 cancers combined      |
|dxCases_0         |           5|Number of diagnosed cases, cancer 0 (Oesophagus)        |
|...               |...         |...                                                     |
|dxCases_10        |          15|Number of diagnosed cases, cancer 10 (Prostate)         |
|dx_0_stage_0      |          16|Stage I (%) at diagnosis, cancer 0 (Oesophagus)         |
|dx_1_stage_0      |          17|Stage I (%) at diagnosis, cancer 1 (Stomach)            |
|...               |...         |...                                                     |
|dx_10_stage_3     |          59|Stage IV (%) at diagnosis, cancer 10 (Prostate)         |
|surv_dx_0         |          60|5-year net survival, cancer 0 (Oesophagus)              |
|...               |...         |...                                                     |
|surv_dx_10        |          70|5-year net survival, cancer 10 (Prostate)               |
|surv_dx_0_stage_0 |          71|5-year net survival, cancer 0 (Oesophagus), Stage I     |
|surv_dx_1_stage_0 |          72|5-year net survival, cancer 1 (Stomach), Stage I        |
|...               |...         |...                                                     |
|surv_dx_10_stage_3|         114|5-year net survival, cancer 10 (Prostate), Stage IV     |
|deaths_dx_0       |         115|Cancer deaths, cancer 0 (Oesophagus)                    |
|...               |...         |...                                                     |
|deaths_dx_10      |         125|Cancer deaths, cancer 10 (Prostate)                     |
|surv_stage_0      |         126|5-year net survival, Stage I, all 11 cancers combined   |
|...               |...         |...                                                     |
|surv_stage_3      |         129|5-year net survival, Stage IV, all 11 cancers combined  |
|stageDist_0       |         130|Stage I (%) at diagnosis, all 11 cancers combined       |
|...               |...         |...                                                     |
|stageDist_3       |         133|Stage IV (%) at diagnosis, all 11 cancers combined      |


*** D. Citation ***
Ward ZJ, Gaba Q, Atun R.
Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study
Lancet Oncol 2024; In Press.